← All OmniTrends reports

Canada Tariffs, Medicare Dialysis Rule, Busiest California Court Day Since September

By OmniLegislation Data Desk

Published October 31, 2026

dailystate-legislatures

A federal executive order further modifying the scope of Canadian products subject to additional duties, with a focus on motor vehicle trade disputes, and a Medicare final rule resetting 2027 dialysis payment rates entered the record on October 30. California's courts also logged 42 opinions, the state's busiest day since September 19.

Why it matters: Those involved in U.S.-Canada motor vehicle trade have a modified duty regime to review, dialysis payment administrators have a new Medicare rule to read, and litigators in California have a court docket running well above its typical weekday pace to work through.

What moved

  • Further Modifying the Scope of Products of Canada Subject to the Additional Duties Imposed To Offset Canadian Discrimination Against the Commerce of the United States With Respect to Motor Vehicles (US): An executive order from the Executive Office of the President further modifies the scope of Canadian products subject to additional duties, with a focus on motor vehicle trade disputes, per the summary. It entered the record as an executive order; no further procedural step is stated. National coverage of tariffs and trade policy ran about two and a half times its trailing pace on October 30, and this order is one of the day's federal actions on that subject.

  • Medicare Program: Calendar Year 2027 Changes to the End-Stage Renal Disease Prospective Payment System, Acute Kidney Injury Dialysis Payment, and ESRD Quality Incentive Program (US): The Centers for Medicare & Medicaid Services adopted a final rule updating the End-Stage Renal Disease Prospective Payment System for calendar year 2027, modifying payment rates for renal dialysis services provided to individuals with acute kidney injury and revising ESRD Quality Incentive Program requirements, per the summary. The rule is adopted; the summary does not state a further procedural step.

  • Schedules of Controlled Substances: Placement of Centanafadine in Schedule III (US): The Department of Justice's Drug Enforcement Administration adopted an interim final rule placing centanafadine, FDA-approved July 24 for ADHD treatment in adults and children 6 and older weighing at least 20 kilograms, into Schedule III of the Controlled Substances Act. The action covers the drug's salts, isomers, and salts of isomers, per the summary.

  • Accreditation, Innovation, and Modernization: The Secretary's Recognition of Accrediting Agencies; Institutional Eligibility Under the Higher Education Act of 1965, as Amended; Student Assistance General Provisions (US): The Department of Education adopted revisions to its accrediting agency recognition regulations, effective October 30, implementing Executive Order 14279. The revisions align the regulations more closely with the Higher Education Act of 1965 and reduce regulatory burden on institutions and accreditors, per the summary; the changes aim to strengthen higher education through accreditation modernization, per the summary.

By the numbers

  • The collection day brought 391 items: 248 federal and 143 spread across 15 states.
  • Federal opinions ran 125, above a trailing weekday average of about 90, about 1.4 times that pace. Federal regulations ran 122, above a trailing weekday average of about 65, about twice that pace.
  • Across all jurisdictions, agency regulations totaled 201 against a trailing weekday average of about 173.
  • California's courts logged 42 opinions, the only record type collected from that state on October 30, more than double its trailing weekday average of about 17, the busiest day for the state since September 19.
  • Virginia added nothing on October 30. Its regulations last appeared in the record on October 23, seven days earlier, against a trailing weekday average of about 14. Its courts last appeared on October 21, nine days earlier, against a trailing weekday average of about one opinion every five days.

Bill actions

No tracked bill carried a logged action dated October 30.

StateTypeCollectedWeekday averageHighest in tracking (date)
USOpinion12590677 (October 2, data load day)
USRegulation122651,303 (June 15, data load day)
USExecutive order10.418 (May 31, data load day)
CAOpinion4217195 (May 18, data load day)
VARegulation014751 (September 3, data load day)
VAOpinion00.211 (April 25, data load day)
FLRegulation36421,763 (September 3, data load day)
AKRegulation2112380 (September 10, data load day)
GAOpinion50.563 (May 30, data load day)

Methodology

"Collected" means the pipeline's collection date, not the date a bill, rule, or opinion was originally filed or issued. Counts are deduplicated processed records from OmniLegislation's own pipeline. Item descriptions come from the pipeline's own summaries of each record. Baselines are trailing 30 day averages for the same kind of day, weekdays measured against weekdays, excluding known data-load days; the highest single-day counts are measured since tracking began on April 5, 2026, and include load days, which are labelled accordingly. Bill actions cover tracked bills only. This report covers October 30, 2026. Bill records originate from LegiScan; court opinions from CourtListener, a Free Law Project service; federal regulations from the Federal Register.